PeptideDB

Indomethacin sodium hydrate

CAS: 74252-25-8 F: C19H21ClNNaO7 W: 433.82

Indomethacin (Indometacin) sodium hydrateis a potent, orally active COX1/2inhibitor with IC50 values of 18 nM and 26 nM
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Indomethacin (Indometacin) sodium hydrateis a potent, orally active COX1/2 inhibitor with IC50 values of 18 nM and 26 nM for COX-1 and COX-2, respectively. Indomethacin sodium hydrateis has anticancer activity and anti-infective activity. Indomethacin sodium hydrateis can be used for cancer, inflammation and viral infection research[1][2][3].
Invitro Indomethacin (Indometacin) sodium hydrateis (0-150 μM; 24 hours; 3LL-D122 cells) has anticancer activity in vitro[2].Indomethacin (Indometacin) sodium hydrateis (0-1000 μM) protects the host cells from damage caused by the virus through activates PKR, resulting in elF2α phosphorylation, and in turn shutting of translation of viral protein and inhibiting replication of the virus (IC50=2 μM)[3]. Cell Viability Assay[2] Cell Line:
Name Indomethacin sodium hydrate
CAS 74252-25-8
Formula C19H21ClNNaO7
Molar Mass 433.82
Transport Room temperature in continental US; may vary elsewhere.
Storage

4°C, protect from light, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)